Approach to Joint Swelling
Any patient presenting with joint swelling associated with pain or stiffness should be referred to and seen by a rheumatologist within 6 weeks of symptom onset 1.
Initial Evaluation Framework
History and Physical Examination
The diagnostic approach begins with careful history taking and clinical examination, which should guide all subsequent testing 1. Clinical examination is the method of choice for detecting arthritis 1.
Key historical elements to assess:
- Timing: Acute hot swollen joint requires urgent evaluation to exclude septic arthritis 2, 3
- Pattern: Number of joints involved (monoarticular vs polyarticular)
- Inflammatory features: Redness, warmth, swelling suggesting synovitis 4
- Duration: Symptoms <6 weeks warrant urgent rheumatology referral 1
- Systemic symptoms: Fever, weight loss, rash
- Exposures: Recent infections, tick bites, sexual history
Confirmatory Imaging
Ultrasonography should be used to confirm arthritis when clinical examination findings are uncertain 1. Point-of-care musculoskeletal ultrasonography is particularly useful for detecting inflammatory arthritis 4.
Critical Decision Point: Exclude Septic Arthritis
For any acute hot swollen joint, joint aspiration with synovial fluid analysis must be performed to rule out septic arthritis 5. This is a medical emergency requiring immediate attention 2, 3.
Rheumatology-led point-of-care polarized light microscopy within 24 hours significantly improves diagnostic accuracy, distinguishing septic arthritis from crystal arthropathy and avoiding unnecessary antibiotics and surgical washouts 6.
Laboratory Testing
When inflammatory arthritis is suspected, obtain:
- Acute phase reactants: ESR and CRP 1
- Rheumatoid factor and anti-CCP antibodies when rheumatoid arthritis is suspected 4
- Synovial fluid analysis: Cell count, Gram stain, culture, and crystal analysis 5, 6
The 2016 EULAR guidelines emphasize that laboratory testing should be guided by history and examination findings rather than ordered reflexively 1.
Risk Stratification for Persistent Disease
If a definitive diagnosis cannot be reached in early undifferentiated arthritis, assess risk factors for persistent and/or erosive disease 1:
- Number of swollen joints
- Elevated acute phase reactants
- Positive rheumatoid factor
- Positive ACPA
- Imaging findings (erosions, synovitis)
Treatment Initiation
Patients at risk of persistent arthritis should be started on DMARDs as early as possible (ideally within 3 months), even if they do not fulfill classification criteria for an inflammatory rheumatologic disease 1.
First-Line Therapy
Methotrexate is the anchor drug and, unless contraindicated, should be part of the first treatment strategy in patients at risk of persistent disease 1.
Adjunctive Therapies
- NSAIDs: Use at minimum effective dose for shortest time possible after evaluating GI, renal, and cardiovascular risks 1
- Systemic glucocorticoids: Use at lowest dose necessary as temporary (<6 months) adjunctive treatment 1
- Intra-articular glucocorticoid injections: Consider for relief of local inflammatory symptoms 1
Monitoring Strategy
The main goal of DMARD treatment is achieving clinical remission 1. Monitor disease activity at 1-3 month intervals until treatment target is reached, using:
- Tender and swollen joint counts
- Patient and physician global assessments
- ESR and CRP
- Composite disease activity measures 1
Common Pitfalls
Delaying rheumatology referral beyond 6 weeks: Early specialist involvement improves outcomes, particularly regarding joint damage and physical function 1
Missing septic arthritis: Always maintain high suspicion for infection in acute monoarticular swelling. The introduction of structured pathways with rapid crystal analysis has reduced misdiagnosis of crystal arthropathy as "culture-negative septic arthritis" from 34% to 17% 6
Failing to aspirate joints: Joint aspiration increased diagnostic accuracy from 50% to 76% in one quality improvement study 6
Waiting for classification criteria before treating: Start DMARDs in at-risk patients even without meeting formal criteria 1
Prolonged glucocorticoid use: Limit to <6 months due to cumulative side effects 1
Comprehensive Care
Include non-pharmacological interventions as adjuncts: dynamic exercises and occupational therapy 1. Address modifiable factors including smoking cessation, dental care, weight control, vaccination status, and comorbidity management 1.